Is it safe?
Can RMD take a bad year?
ResMed holds $996M more cash than debt, so a bad year is a question about profits, not about lenders.
$996M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 10.48
Altman Z-score · safe zone, above 3
- Debt / equity
- 0.10×
Debt / equity
Details›
- Total debtQ3 2026
- $664M
- Cash and short-term investments
- $1.66B
- Net cash
- $996M
- EBITDA, trailing twelve months
- $2.11B
- Operating profit, trailing twelve months
- $1.89B
- Debt / equity
- 0.10×
- Total debt / EBITDA
- 0.31×
- Annualised volatilitytwo years of daily moves
- 28%
- Worst drawdown on file
- −54%
- Below its 52-week high
- −19%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Medical Instruments & Supplies
Ranks #3 of 27 by Smart Score